476 results on '"Morris, Luc G. T."'
Search Results
2. LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features
3. Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial
4. FAT1 expression in T-cell acute lymphoblastic leukemia (T-ALL) modulates proliferation and WNT signaling
5. Cytology-based Cancer Surgery of the Head and Neck (CyCaS-HN): a prospective, randomized, controlled clinical trial
6. Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity
7. Improved prediction of immune checkpoint blockade efficacy across multiple cancer types
8. Pre-treatment serum albumin and mutational burden as biomarkers of response to immune checkpoint blockade
9. Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape
10. The association between tumor mutational burden and prognosis is dependent on treatment context
11. Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy
12. Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
13. Risk of Carcinoma in Pleomorphic Adenomas of the Parotid
14. Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
15. Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy
16. Immunogenic neoantigens derived from gene fusions stimulate T cell responses
17. Tumor mutational load predicts survival after immunotherapy across multiple cancer types
18. Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer
19. Robust prediction of patient outcomes with immune checkpoint blockade therapy for cancer using common clinical, pathologic, and genomic features
20. Prognostic impact of intra- and peritumoral immune cell subpopulations in head and neck squamous cell carcinomas – comprehensive analysis of the TCGA-HNSC cohort and immunohistochemical validation on 101 patients
21. Validation of a Machine Learning Model to Predict Immunotherapy Response in Head and Neck Squamous Cell Carcinoma.
22. Transorbital embolization of cavernous sinus dural arterio-venous malformations with surgical exposure and catheterization of the superior ophthalmic vein.
23. CD66b as a prognostic and predictive biomarker in patients with non-small cell lung cancer treated with checkpoint blockade immunotherapy
24. American Thyroid Association Guidelines and National Trends in Management of Papillary Thyroid Carcinoma
25. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
26. Additional file 2 of Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape
27. Association Between Toxic Effects and Survival in Patients With Cancer and Autoimmune Disease Treated With Checkpoint Inhibitor Immunotherapy
28. Cervical Pneumatocele Following Total Thyroidectomy Presenting as an Air Thyrogram
29. Transorbital embolization of cavernous sinus dural arterio-venous malformations with surgical exposure and catheterization of the superior ophthalmic vein
30. Mutations in KMT2C, BCOR and KDM5C Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer
31. Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques
32. Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance
33. The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform
34. Wide Inter-institutional Variation in Performance of a Molecular Classifier for Indeterminate Thyroid Nodules
35. Development and Characterization of MYB-NFIB Fusion Expression in Adenoid Cystic Carcinoma
36. MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer
37. Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers
38. Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer
39. Augmented reality‐enhanced navigation in endoscopic sinus surgery: A prospective, randomized, controlled clinical trial
40. Assessing the Evidence for Circulating Tumor HPV DNA in Patients With Oropharyngeal Cancer.
41. Outcomes Among Patients With or Without Obesity and With Cancer Following Treatment With Immune Checkpoint Blockade
42. Abstract P054: Immune determinants of the association between tumor mutational burden and immunotherapy response across cancer types
43. Reduced impact of nodal metastases as a prognostic factor for tonsil cancer in the HPV era
44. Ethical Considerations When Counseling Patients With Thyroid Cancer About Surgery vs Observation
45. Transoral robotic surgery adoption and safety in treatment of oropharyngeal cancers
46. Impact of tumor mutational burden on checkpoint inhibitor drug eligibility and outcomes across racial groups
47. Improved prediction of immune checkpoint blockade efficacy across multiple cancer types
48. 3p Arm Loss and Survival in Head and Neck Cancer: An Analysis of TCGA Dataset
49. Increasing diagnosis of subclinical thyroid cancers leads to spurious improvements in survival rates
50. Therapeutic Targeting of Tumor Suppressor Genes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.